PsychedelicNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Takes Aim at Non-Psychoactive Cannabis-based Consumer Goods Market

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains focused on developing its strategic portfolio. An article discussing the company reads: “As pending legislation authorizing the cultivation of hemp without drug enforcement oversight opens the potential for U.S. federal government friendliness toward cannabis production, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is busy pledging its visionary portfolio to the market for consumer goods arising from the cannabis species’ non-psychoactive varieties. … Global Hemp Group joined other players in the delicate industrial hemp arena in praising Sen. Mitch McConnell’s long-time efforts to remove low-psychoactive chemical plants from the Drug Enforcement Administration’s listing of controlled substances, as well as his recent announcement of a Hemp Farming Act Senate bill that would permanently reduce hemp to agricultural oversight (http://cnw.fm/4jiXX).”

To view the full article, visit http://cnw.fm/Jk1oH

About Global Hemp Group Inc.

Global Hemp Group (“GHG”) is a publicly traded company founded in 2014, headquartered in British Columbia, Canada with base operations in Montreal and Los Angeles. The Company is focused on the cultivation of hemp and the extraction of cannabinoids, and collaboration with companies that will enable GHG to develop and implement the Hemp Agro-Industrial Zone (HAIZ) concept. Through partnerships, joint ventures and acquisitions, the Company will capture cash flow, revenues and value, and establish a greater collective valuation. For more information, visit the company’s website at www.GlobalHempGroup.com.

More from PsychedelicNewsBreaks

• PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
• PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
• PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for Dec. 2

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) PsychedelicNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. PNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled visibility, recognition and brand awareness. PNW is where news, content and information converge.

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/disclaimer/

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com